Shrewsbury, MA, United States of America

Paul G Gregory



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2002-2007

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Paul G Gregory

Introduction

Paul G Gregory is an accomplished inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of hepatocyte research, holding a total of three patents. His work focuses on enhancing the function of isolated liver cells, which has important implications for medical treatments.

Latest Patents

One of his latest patents is titled "In vivo induction for enhanced function of isolated hepatocytes." This invention features a liver cell culture comprising hepatocytes that exhibit increased detoxification enzyme activity when isolated from a liver of a donor that had been administered at least one induction agent prior to the isolation of hepatocyte cells. The induced hepatocytes are utilized in a bioreactor and cultured to produce hepatocyte cell products or metabolize toxins added to the culture. The bioreactor is either an integral part of or used in conjunction with a liver assist device designed to treat patients in need of liver support.

Career Highlights

Paul G Gregory is currently employed at Organogenesis, Inc., where he continues to innovate in the field of liver cell research. His work has the potential to improve treatment options for patients with liver conditions, showcasing his commitment to advancing medical science.

Collaborations

He collaborates with notable colleagues, including Susan J Sullivan and Paul A DiMilla, who contribute to the research and development efforts at Organogenesis, Inc.

Conclusion

Paul G Gregory's contributions to hepatocyte research and his innovative patents highlight his role as a significant figure in the field of medical science. His work not only advances our understanding of liver function but also paves the way for improved therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…